Antibiotic resistance is the ability of bacteria to resist the effects of antibiotics ... of the antibiotics by enzymes referred to as the beta-lactamases. There are two broad classes of ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...

Antibiotic resistance is perhaps the most important ... efflux pumps to expel antibiotics and beta-lactamase enzymes to inactivate beta-lactam antibiotics. New antibiotics must overcome resistance ...

is one of the major mechanisms of antibiotic resistance. Plasmid borne genes encoding modifying enzymes such as beta-lactamases, that confer resistance to penicillins and related antibiotics, or, more ...

AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

The bacteria were analysed using whole genome sequencing, which identified antimicrobial resistance genes in all 17 species .

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

Research presented at the World Microbe Forum (online, 20–24 June 2021) has detailed the use of native mass spectrometry in the evaluation of how potential inhibitors work on antibiotic-resistant ...